{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:53:16Z","timestamp":1772808796837,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T00:00:00Z","timestamp":1411516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s10072-014-1960-9","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T23:38:29Z","timestamp":1411515509000},"page":"465-467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Recurrence of disease activity after repeated Natalizumab withdrawals"],"prefix":"10.1007","volume":"36","author":[{"given":"Laura","family":"Ferr\u00e8","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Moiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Sangalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Barcella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,24]]},"reference":[{"issue":"16","key":"1960_CR1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJM200304173481614","volume":"348","author":"A Chaudhuri","year":"2003","unstructured":"Chaudhuri A, Behan PO (2003) Natalizumab for relapsing multiple sclerosis. N Engl J Med 348(16):1598\u20131599","journal-title":"N Engl J Med"},{"issue":"4","key":"1960_CR2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","volume":"9","author":"DB Clifford","year":"2010","unstructured":"Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A (2010) Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9(4):438\u2013446","journal-title":"Lancet Neurol"},{"issue":"9","key":"1960_CR3","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00415-011-5996-y","volume":"258","author":"J Havla","year":"2011","unstructured":"Havla J, Gerdes LA, Meinl I, Krumbholz M, Faber H, Weber F et al (2011) De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate. J Neurol 258(9):1665\u20131669","journal-title":"J Neurol"},{"issue":"22","key":"1960_CR4","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.0b013e31821e7c8a","volume":"76","author":"PW O\u2019Connor","year":"2011","unstructured":"O\u2019Connor PW, Goodman A, Kappos L, Lublin FD, Miller DH, Polman C et al (2011) Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology 76(22):1858\u20131865","journal-title":"Neurology"},{"issue":"17","key":"1960_CR5","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1212\/WNL.0000000000000355","volume":"82","author":"RJ Fox","year":"2014","unstructured":"Fox RJ, Cree BA, De S\u00e8ze J, Gold R, Hartung HP et al (2014) MS disease activity in restore: a randomized 24\u00a0week natalizumab treatment interruption study. Neurology 82(17):1491\u20131498","journal-title":"Neurology"},{"key":"1960_CR6","doi-asserted-by":"crossref","unstructured":"Sangalli F, Moiola L, Ferr\u00e8 L, Radaelli M, Barcella V, Rodegher M, Colombo B, et al. (2014) Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients. Mult Scler Relat Disord","DOI":"10.1016\/j.msard.2014.04.003"},{"issue":"5","key":"1960_CR7","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00415-012-6808-8","volume":"260","author":"J Havla","year":"2013","unstructured":"Havla J, Tackenberg B, Hellwig K, Meinl I, Krumbholz M et al (2013) Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis. J Neurol 260(5):1382\u20131387","journal-title":"J Neurol"},{"issue":"9","key":"1960_CR8","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1177\/1352458512468498","volume":"19","author":"A Laroni","year":"2013","unstructured":"Laroni A, Brogi D, Milesi V, Abate L, Uccelli A et al (2013) Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption. Mult Scler 19(9):1236\u20131237","journal-title":"Mult Scler"},{"issue":"4","key":"1960_CR9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamaneurol.2013.6240","volume":"71","author":"M Cohen","year":"2014","unstructured":"Cohen M, Maillart E, Tourbah A, De S\u00e8ze J, Vukusic S et al (2014) Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study. JAMA Neurol 71(4):436\u2013441","journal-title":"JAMA Neurol"},{"key":"1960_CR10","unstructured":"Martinelli V, Colombo B, Dalla Costa G, Dalla Libera D, Moiola et al. (2013) Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning. Mult Scler"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-014-1960-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-014-1960-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-014-1960-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:19:01Z","timestamp":1559121541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-014-1960-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,24]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s10072-014-1960-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,24]]}}}